Last reviewed · How we verify
OMT strategy
OMT strategy refers to Optimal Medical Therapy, a comprehensive treatment approach combining multiple pharmacological agents to manage cardiovascular disease.
OMT (Optimal Medical Therapy) strategy is a comprehensive treatment approach that combines multiple pharmacological and lifestyle interventions to optimize cardiovascular outcomes. Used for Cardiovascular disease management and risk reduction, Coronary artery disease.
At a glance
| Generic name | OMT strategy |
|---|---|
| Sponsor | Beijing Anzhen Hospital |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Mechanism of action
OMT strategy is not a single drug but rather a clinical protocol that combines evidence-based medications (typically including antiplatelet agents, beta-blockers, ACE inhibitors, and statins) to optimize outcomes in cardiovascular patients. This multi-drug approach targets multiple pathways involved in atherosclerosis, thrombosis, and cardiac dysfunction to reduce morbidity and mortality.
Approved indications
- Acute coronary syndrome management
- Chronic coronary artery disease
- Post-myocardial infarction secondary prevention
Common side effects
Key clinical trials
- Coronary CT-Derived FFR-Guided Strategy Versus Medical Therapy (NA)
- Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques (PHASE4)
- A Multiple Component Mobile-aid Pain Reduction Intervention to Decrease Myofascial Pain (NA)
- ISCHEMIA-Chronic Kidney Disease Trial (PHASE4)
- SGLT-2 Inhibitors in Prevention of Post-procedural Renal and Cardiovascular Complications aFter PCI Among Patients With Diabetes Mellitus and Coronary Artery Disease: a Prospective, Randomized, Pilot Study (SAFE-PCI) (PHASE4)
- EndovaScular Versus mediCaL mAnagement of Uncomplicated Type B Intramural heMatoma Trial (ESCLAIM) (NA)
- Effectiveness of Osteopathic Manipulative Therapy in Nonsynostotic Plagiocephaly (NA)
- Effects of Osteopathic Manipulative Treatment in People With Neurogenic Bowel Dysfunction (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |